Related Experiment Videos
Warfarin and uric acid after myocardial infarction
Acta Medica Scandinavica
|January 1, 1986
Summary
Warfarin did not affect serum urate levels in patients recovering from myocardial infarction. Uric acid levels decreased similarly in both warfarin and placebo groups, indicating no urate-lowering effect from warfarin.
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- Myocardial infarction (MI) management often involves anticoagulation.
- The impact of warfarin on serum urate concentration requires clarification.
- Previous studies suggest some oral anticoagulants may influence urate levels.
Purpose of the Study:
- To investigate the effect of warfarin on serum urate concentration in patients post-myocardial infarction.
- To compare changes in serum urate levels between warfarin-treated and placebo groups.
Main Methods:
- Prospective, randomized, placebo-controlled study design.
- Inclusion of 50 patients following myocardial infarction.
- Monitoring of serum urate levels over an average of 10 months (range 6-20 months).
Main Results:
- Serum urate levels decreased in both the warfarin (n=23) and placebo (n=27) groups.
- The magnitude of reduction in serum urate was comparable between the two groups.
- Warfarin did not demonstrate a significant urate-lowering effect.
Conclusions:
- Warfarin does not appear to influence serum urate concentration.
- Unlike some other oral anticoagulants, warfarin does not exert a urate-lowering effect.
- Findings suggest warfarin can be used in post-MI patients without concern for altered uric acid levels.